Checkpoint receptors such as PD1 /PD-L1 and CTLA4 can be blocked to relieve CD8+ T cells exhaustion and restart prime, respectively, thereby eradicating tumor cells that express antigens (Farhood, Najafi & Mortezaee, 2019). Here, CTLA4 is linked to neoplasm.